Avalon GloboCare Corp. (NASDAQ: ALBT) is dedicated to developing and delivering innovative, transformative, precision diagnostics and clinical laboratory services. Our main strategy is to acquire ownership or license rights in precision diagnostic assets, genetic testing and clinical laboratory companies through joint ventures, share ownership structures or distribution rights. We plan to play a leading role in the innovation of diagnostic testing, utilizing proprietary technology to deliver precise, genetics-driven results. As a first major step into the laboratory market, we completed an acquisition of a 40% membership interest in Laboratory Services MSO, LLC, which closed in February 2023.
Company Profile
Industry Classifications
Sector:
Healthcare
Industry:
Healthcare Providers
NAICS:
General Medical and Surgical Hospitals (622110)
SIC:
General Medical and Surgical Hospitals (8062)
Contact Information
Investor Relations
Crescendo Communications, LLC
T: (212) 671-1020
avco@crescendo-ir.com
Company Contact
Avalon GloboCare Corp.
4400 Route 9 South
Suite 3100
Freehold, NJ 07728
United States
T: 732-780-4400
F: 732-780-5600
info@avalon-globocare.com